ScholarWorks@Korea University: Yuk, Soon Hong

Detailed Information

Yuk, Soon Hong (육순홍)

College of Pharmacy (Department of Pharmaceutical Science)

Research Area

Tel 044-860-1612
Homepage

ResearcherID ORCiD Scopus Google Scholar ID ResearchGate

Keyword

Pluronic nanoparticles:5||Doxorubicin:4||Photodynamic therapy:3||Chemotherapy:3||cancer therapy:3||Core/shell nanoparticles:3||Pluronic:3||Pluronics:3||Nanoparticles:3||Docetaxel:3||sustained release:2||raloxifene HCl:2||docetaxel:2||temperatureinduced phase transition:2||nanoparticles:2||Atorvastatin calcium:2||drug delivery system:2||Solgel transition:2||controlled release:2||dissolution rate:2||Tumor targeting:2||Pluronic F68:2||Cancertargeting therapy:2||peptide drug:2||Composite nanoparticles:2||Magnetic resonance imaging:2||solubility:2||solid dispersion:2||paclitaxel:2||Molecular imaging:2||pluroic F68:2||Macromolecules:1||Leukocytes:1||lipopolysaccharides:1||Ultrasuperparamagnetic iron oxide:1||Isostructural solvate:1||vesicle fusion:1||Vesicle:1||glycol chitosan/heparin composite:1||Nanoencapsulation:1||temperature  induced phase transition:1||Theragnosis:1||siRNA therapy:1||Nanomedicine:1||in vivo biodistribution:1||PLGA microspheres:1||Multicore vesicle nanoparticles:1||Targeted Delivery:1||in vivo MR (magnetic resonance) imaging:1||Korea red ginseng:1||Small molecules:1||Hydrophilic nanoparticles:1||Rheumatoid arthritis:1||apoptosis:1||Prodrug:1||The multilayer nanoparticles:1||Doxorubicininduced apoptosistargeted:1||chemotherapy:1||The composite nanoparticles:1||cell death:1||Solidstate characterization:1||Lipid bilayers:1||Sustained delivery of exenatide:1||cancer targetability:1||core/shell nanoparticles:1||enhanced permeability and retention effect:1||Pluornics:1||selfassembly:1||acidifier:1||Temperatureinduced phase transition:1||Personalized medicine:1||Tween 80/soybean oil:1||antitumor efficacy:1||Imaging:1||Tumortargeting:1||Nanoparticle:1||Chlorin e6:1||drugeluting stents:1||ultrasonic atomizing spray:1||Phthalocyanine:1||Nearinfrared photonics:1||Heparin.:1||Vascular endothelial growth factor:1||In situ gel:1||polysaccharide:1||prodrug:1||green synthesis:1||Nanoparticles/polymer mixture:1||tumor necrosis factoralpha:1||metastatic lymphatics:1||primary tumor targeting:1||hyaluronic acid (HA):1||Antitumor efficacy:1||layerbylayer approach:1||molecular imaging agent:1||multicomponent system:1||enhancement of tumortargeting capability:1||Lipiodol (R):1||Hyaluronic acid:1||Pluronic/PEG composite NPs:1||pHSensitive Release of Anticancer Drug:1||Pluronic F127:1||red ginseng:1||Sphingosine1phosphate:1||acetylation:1||combination therapy:1||storage and stability:1||Caspase3:1||Heparin:1||Extravasation:1||macrophage:1||Lymph node:1||lymphatic tracking:1||Isostructural desolvate:1||Layerbylayer approach:1||poly(lactidecoglycolide) (PLGA):1||Pluronic/liposome composite nanoparticles:1||Optical imaging:1||mannitol:1||Phototermal therapy:1||Regeneration of ischemic heart:1||Skin microbiota:1||Phase transition:1||S1P receptor:1||photodynamic therapy:1||Apoptosis:1||Doxorubicin prodrug:1||Polysaccharides:1||Solutol:1||Effective cancer therapy:1||sulfonic acid:1||microspheres:1||Multifunctional nanoparticles:1||Deformability:1||Photothermal therapy:1||human growth hormone:1||Hyperthermia:1||Tumortargeting characteristic:1||panaxydol:1||panaxynol:1||Pluronic/heparin nanoparticles:1||silver nanoparticles:1||wound dressing:1||Deep penetration:1||Radiotherapy:1||Gold nanoparticles:1||Superporous hydrogel:1||Drug release:1||Exenatide:1||Targeting enhancement:1||singlewalled carbon nanotubes:1||Tenofovir disoproxil fumarate:1||chitosan/heparin composite:1||protein drug:1||drug candidate:1||salt:1||valsartan:1||In vivo imaging:1||triptorelin acetate:1||HPMC:1||multicore vesicle NPs:1||Core/Shell Nanoparticles with DrugLoaded Lipid Cores:1||Panax ginseng CA Meyer:1||In vitro drug release:1||degradation kinetics:1||linseed hydrogel:1||Multistage nanostructure:1||Combination therapy:1||multilayer nanoparticles:1||Ultrasoundinduced:1||annulus fibrosus:1||polyethylene glycol:1||Layer by layer approach:1||Degree of substitution:1||Stability:1||Cancer:1||PLGA/PEVA composite:1||Lecithin:1||Temperatureinduced gel formation:1||antiacne:1||antibacterial ingredient:1||Linseed polysaccharides:1||Cancer therapy:1||thermal analysis:1||antimicrobial studies:1||Linseed hydrogel:1||Swellingdeswelling:1||Sustained delivery:1||Type 2 diabetes mellitus:1||in vivo:1||solid state characterization:1||polyoxalate:1||Multilayer nanoparticles:1||pluronic:1||Glycol chitosan nanoparticles:1||stability:1||particle size:1||Drug delivery:1||Glycol chitosan:1||Panax ginseng:1||Clinical study:1||

STATISTICS: Total View :6,907,726; Today View :7,340

RSS_1.0 RSS_2.0 ATOM_1.0

145 Anam-ro, Seongbuk-gu, Seoul, 02841, Korea+82-2-3290-2963

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Keyword

BROWSE